San Diego, July 30 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM), will report second quarter 2009 and year-to-date financial results after market close on Thursday, August 6, 2009. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.
Conference Call Information:
Domestic callers: 1-800-706-7749
International callers: +1-617-614-3474
Passcode: 42079558
Webcast information: Visit http://ir.sequenom.com.
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).
A webcast replay will be available on the SEQUENOM Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-888-286-8010 for domestic callers, or +1-617-801-6888 for international callers, and entering reservation code 47416001.
About SEQUENOM
SEQUENOM is a life sciences company committed to providing the best genetic analysis products that translate the results of genomic science into solutions for molecular diagnostics, biomedical research, translational research and molecular medicine applications. As an industry innovator in DNA detection technology, SEQUENOM's MassARRAY((R)) system allows a direct mass measurement of nucleic acids, providing unparalleled precision and quantification. On the diagnostics front, SEQUENOM is developing a comprehensive portfolio of prenatal test methods by combining the versatility of the MassARRAY system with the company's SEQureDx(TM) technology, which enables the detection of circulating cell-free fetal nucleic acids in a maternal blood sample. The company is also developing tests for oncology, infectious diseases and other disorders. The company was founded in 1994 and is headquartered in San Diego, California. For more information please visit http://www.sequenom.com.
SEQUENOM((R)), SEQureDx(TM), and MassARRAY((R)) are trademarks of SEQUENOM, Inc. All other trademarks and service marks are the property of their respective owners.
Company Contact Investor Relations Contact Media Relations
Ian Clements, PhD Lippert/Heilshorn & Pure Communications
Associates
Sr. Director, Corp. Jody Cain (jcain@lhai.com) Sheryl Seapy
Communications
+1 (858) 202-9000 +1 (310) 691-7100 +1 (949) 608-0841
SOURCE SEQUENOM, Inc.
For further information: Company: Ian Clements, PhD, Sr. Director, Corp. Communications of SEQUENOM, Inc., +1-858-202-9000; Investor Relations: Jody Cain of Lippert, Heilshorn & Associates, +1-310-691-7100, jcain@lhai.com; Media Relations: Sheryl Seapy of Pure Communications, +1-949-608-0841
© PR Newswire
